IL22 and atherosclerosis: On the one hand, IL-22 proved to be proatherogenic by activation of crucial inflammatory signaling pathway IL6/JAK2/STAT3 (119), which in turn attracted more inflammatory cells, facilitated the differentiation of Th17, and enabled SMC migration and modification into a less flexible phenotype, thus worsening the progression of atherosclerosis (117, 118).